The high cost of spasticity in multiple sclerosis to individuals and society

Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life

(2013) P. Flachenecker et al.   ACTA NEUROLOGICA SCANDINAVICA

Costs and quality of life in multiple sclerosis patients with spasticity

(2013) J. Svensson et al.   ACTA NEUROLOGICA SCANDINAVICA

Multiple sclerosis spasticity daily management: retrospective data from Europe

(2013) Thomas Berger   Expert Review of Neurotherapeutics

Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines

(2013) Ralf Gold et al.   Expert Review of Neurotherapeutics

Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice

(2013) Carlo Pozzilli   Expert Review of Neurotherapeutics

Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database

(2013) I. S. Mackenzie et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Spasticity Management in Multiple Sclerosis

(2013) Christina Hughes et al.   Physical Medicine and Rehabilitation Clinics of North America

Economic Considerations of the Treatment of Ankylosing Spondylitis

(2012) John D. Reveille et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Sativex® in multiple sclerosis spasticity: a cost–effectiveness model

(2012) John Slof et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Cost–effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature

(2012) Timm D Kirchhoff et al.   Expert Review of Pharmacoeconomics & Outcomes Research

The value of early intervention in RA—a window of opportunity

(2011) Ferdinand Breedveld   CLINICAL RHEUMATOLOGY

Assistive devices, home adjustments and external help in rheumatoid arthritis

(2011) Kaja Põlluste et al.   DISABILITY AND REHABILITATION

Clinical assessment and management of spasticity: a review

(2010) T. Rekand   ACTA NEUROLOGICA SCANDINAVICA

Socioeconomic Trends in Hospitalization for Multiple Sclerosis

(2010) Shivanand P. Lad et al.   NEUROEPIDEMIOLOGY

The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US

(2010) Jasmina I. Ivanova et al.   PHARMACOECONOMICS

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

(2009) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

Multiple sclerosis—a global disorder and still poorly managed

(2008) Alan J Thompson   LANCET NEUROLOGY